Bain Capital Public Equity Management, LLC - Q2 2014 holdings

$4.13 Billion is the total value of Bain Capital Public Equity Management, LLC's 55 reported holdings in Q2 2014. The portfolio turnover from Q1 2014 to Q2 2014 was 90.0% .

 Value Shares↓ Weighting
NewAIR PRODS & CHEMS INC$180,467,0001,403,100
+100.0%
4.37%
CSCO NewCISCO SYS INC$179,415,0007,219,900
+100.0%
4.35%
BRCM SellBROADCOM CORPcl a$173,896,000
-34.0%
4,684,700
-44.1%
4.21%
-40.0%
MON SellMONSANTO CO NEW$168,856,000
-40.7%
1,353,660
-45.9%
4.09%
-46.1%
ULTA BuyULTA SALON COSMETCS & FRAG I$157,448,000
+19.8%
1,722,436
+27.7%
3.82%
+9.0%
HTZ BuyHERTZ GLOBAL HOLDINGS INC$157,112,000
+82.2%
5,605,147
+73.2%
3.81%
+65.9%
TWTR NewTWITTER INC$147,687,0003,604,761
+100.0%
3.58%
YOKU BuyYOUKU TUDOU INCsponsored adr$142,723,000
+25.7%
5,981,700
+47.7%
3.46%
+14.4%
SIG NewSIGNET JEWELERS LIMITED$139,034,0001,257,200
+100.0%
3.37%
KORS NewMICHAEL KORS HLDGS LTD$137,105,0001,546,591
+100.0%
3.32%
AAP SellADVANCE AUTO PARTS INC$126,836,000
-11.0%
940,084
-16.6%
3.07%
-19.0%
MDVN BuyMEDIVATION INC$122,472,000
+34.2%
1,588,890
+12.1%
2.97%
+22.1%
VMW SellVMWARE INC$119,048,000
-34.8%
1,229,709
-27.3%
2.88%
-40.7%
ABBV NewABBVIE INC$105,074,0001,861,700
+100.0%
2.55%
RL NewRALPH LAUREN CORPcl a$104,063,000647,600
+100.0%
2.52%
WMB NewWILLIAMS COS INC DEL$102,485,0001,760,600
+100.0%
2.48%
AET BuyAETNA INC NEW$100,636,000
+96.9%
1,241,200
+82.0%
2.44%
+79.2%
CRM NewSALESFORCE COM INC$86,334,0001,486,462
+100.0%
2.09%
IDIX SellIDENIX PHARMACEUTICALS INC$81,087,000
+49.3%
3,364,623
-62.6%
1.96%
+35.9%
PCP SellPRECISION CASTPARTS CORP$79,600,000
-23.7%
315,371
-23.6%
1.93%
-30.5%
PTCT  PTC THERAPEUTICS INC$74,813,0000.0%2,862,0250.0%1.81%
-9.0%
DG SellDOLLAR GEN CORP NEW$74,614,000
-61.5%
1,300,809
-62.8%
1.81%
-65.0%
MHK NewMOHAWK INDS INC$73,597,000532,000
+100.0%
1.78%
TV SellGRUPO TELEVISA SAspon adr rep ord$72,337,000
-9.9%
2,108,329
-12.6%
1.75%
-18.0%
P BuyPANDORA MEDIA INC$72,156,000
+35.6%
2,445,966
+39.4%
1.75%
+23.4%
EDU SellNEW ORIENTAL ED & TECH GRP Ispon adr$70,348,000
-39.9%
2,647,642
-33.6%
1.70%
-45.3%
TDG NewTRANSDIGM GROUP INC$66,280,000396,271
+100.0%
1.61%
Q  QUINTILES TRANSNATIO HLDGS I$64,154,000
+5.0%
1,203,8640.0%1.56%
-4.4%
TRIP SellTRIPADVISOR INC$62,701,000
-16.3%
577,041
-30.2%
1.52%
-23.9%
CTRP SellCTRIP COM INTL LTD$61,723,000
-30.5%
963,820
-45.3%
1.50%
-36.8%
MGA NewMAGNA INTL INC$61,269,000568,853
+100.0%
1.48%
FOXA NewTWENTY FIRST CENTY FOX INCcl a$60,981,0001,734,870
+100.0%
1.48%
ST SellSENSATA TECHNOLOGIES HLDG NV$55,940,000
-45.9%
1,195,804
-50.7%
1.36%
-50.8%
HD NewHOME DEPOT INC$51,693,000638,500
+100.0%
1.25%
3106PS SellDELPHI AUTOMOTIVE PLC$49,158,000
-60.4%
715,131
-60.9%
1.19%
-64.0%
SEAS SellSEAWORLD ENTMT INC$48,932,000
-31.2%
1,727,200
-26.6%
1.19%
-37.3%
SLM BuySLM CORP$43,449,000
-44.7%
5,228,500
+63.0%
1.05%
-49.6%
CYH NewCOMMUNITY HEALTH SYS INC NEW$39,845,000878,227
+100.0%
0.97%
SFUN NewSOUFUN HLDGS LTDadr$39,740,0004,059,254
+100.0%
0.96%
RNG BuyRINGCENTRAL INCcl a$36,690,000
+36.5%
2,425,000
+63.3%
0.89%
+24.2%
HCA SellHCA HOLDINGS INC$36,623,000
-45.5%
649,576
-49.3%
0.89%
-50.4%
LOCK NewLIFELOCK INC$35,116,0002,515,449
+100.0%
0.85%
DRNA  DICERNA PHARMACEUTICALS INC$34,157,000
-20.1%
1,513,4000.0%0.83%
-27.2%
MHFI SellMCGRAW HILL FINL INC$33,493,000
-33.9%
403,387
-39.3%
0.81%
-39.9%
MJN SellMEAD JOHNSON NUTRITION CO$26,857,000
-74.2%
288,253
-77.0%
0.65%
-76.5%
RXN NewREXNORD CORP NEW$25,712,000913,400
+100.0%
0.62%
RDUS NewRADIUS HEALTH INC$23,719,0001,824,524
+100.0%
0.58%
ODP NewOFFICE DEPOT INC$23,561,0004,140,800
+100.0%
0.57%
SHPG NewSHIRE PLCsponsored adr$21,642,00091,900
+100.0%
0.52%
ACHN NewACHILLION PHARMACEUTICALS IN$17,007,0002,246,632
+100.0%
0.41%
ZFGN NewZAFGEN INC$13,183,000666,480
+100.0%
0.32%
FMI NewFOUNDATION MEDICINE INC$12,035,000446,400
+100.0%
0.29%
NewARROWHEAD RESH CORP$11,873,000829,710
+100.0%
0.29%
CNCE  CONCERT PHARMACEUTICALS INC$11,593,000
-24.9%
1,147,8330.0%0.28%
-31.6%
DVAX SellDYNAVAX TECHNOLOGIES CORP$8,440,000
-34.7%
5,274,936
-26.2%
0.20%
-40.4%
ATEN ExitA10 NETWORKS INC$0-341,417
-100.0%
-0.14%
TRVN ExitTREVENA INC$0-799,998
-100.0%
-0.17%
CYTK ExitCYTOKINETICS INC$0-687,260
-100.0%
-0.17%
AGIO ExitAGIOS PHARMACEUTICALS INC$0-207,889
-100.0%
-0.22%
VIV ExitTELEFONICA BRASIL SAsponsored adr$0-521,352
-100.0%
-0.30%
ARWR ExitARROWHEAD RESH CORP$0-717,500
-100.0%
-0.31%
YNDX ExitYANDEX N V$0-555,500
-100.0%
-0.45%
FRAN ExitFRANCESCAS HLDGS CORP$0-1,264,300
-100.0%
-0.61%
SBH ExitSALLY BEAUTY HLDGS INC$0-905,100
-100.0%
-0.66%
WIX ExitWIX COM LTD$0-1,127,930
-100.0%
-0.69%
RKUS ExitRUCKUS WIRELESS INC$0-2,229,400
-100.0%
-0.72%
NOK ExitNOKIA CORPsponsored adr$0-5,586,225
-100.0%
-1.09%
ESRX ExitEXPRESS SCRIPTS HLDG CO$0-549,500
-100.0%
-1.10%
HMIN ExitHOME INNS & HOTELS MGMT INCspon adr$0-1,380,804
-100.0%
-1.19%
AMCX ExitAMC NETWORKS INCcl a$0-634,160
-100.0%
-1.23%
PANW ExitPALO ALTO NETWORKS INC$0-687,200
-100.0%
-1.26%
XYL ExitXYLEM INC$0-1,741,763
-100.0%
-1.69%
AMZN ExitAMAZON COM INC$0-227,000
-100.0%
-2.03%
RTN ExitRAYTHEON CO$0-1,024,368
-100.0%
-2.70%
APD ExitAIR PRODS & CHEMS INC$0-1,514,700
-100.0%
-4.80%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

  • Brookside Capital Investors, L.P. #1
  • Brookside Capital Partners Fund, L.P. #2
  • Brookside Capital Trading Fund, L.P. #3
  • Brookside Capital Investors II, L.P. #4
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2014-08-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CITRIX SYS INC18Q3 20186.7%
QUINTILES TRANSNATIO HLDGS I18Q3 20173.5%
AFFIMED N V16Q1 20191.0%
BALL CORP13Q1 20197.2%
RADIUS HEALTH INC13Q2 20178.4%
TRANSDIGM GROUP INC11Q2 201610.1%
ULTA SALON COSMETCS & FRAG I11Q4 20155.4%
VIASAT INC11Q2 20177.5%
AETNA INC NEW11Q2 20174.1%
GODADDY INC10Q1 20195.7%

View Bain Capital Public Equity Management, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Bain Capital Public Equity Management, LLC Q2 2014 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Affimed N.V.February 14, 20192,362,8133.8%
IMMUNE DESIGN CORP.February 14, 2019892,0611.8%
REVA Medical, Inc.February 14, 2019296,502,2207.2%
MULESOFT, INCFebruary 14, 20181,404,0251.9%
CONCERT PHARMACEUTICALS, INC.February 28, 20141,147,8336.7%
IDENIX PHARMACEUTICALS INCFebruary 12, 201413,115,8589.8%
NORTHSTAR REALTY FINANCE CORP.February 12, 20147,657,7812.6%
PORTOLA PHARMACEUTICALS INCFebruary 12, 2014400,0001.0%
Dicerna Pharmaceuticals IncFebruary 10, 20141,337,0008.0%
RingCentral IncFebruary 07, 2014471,0735.5%

View Bain Capital Public Equity Management, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2020-11-16
13F-HR2020-08-14
13F-HR2020-05-15
13F-HR2020-02-14
13F-HR2019-11-14
13F-HR2019-08-14
13F-HR2019-05-15
13F-HR2019-02-14
SC 13G/A2019-02-14
SC 13G/A2019-02-14

View Bain Capital Public Equity Management, LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (4126808000.0 != 4126809000.0)

Export Bain Capital Public Equity Management, LLC's holdings